CN105287798A - 降脂瘦身复原丸 - Google Patents
降脂瘦身复原丸 Download PDFInfo
- Publication number
- CN105287798A CN105287798A CN201510702945.2A CN201510702945A CN105287798A CN 105287798 A CN105287798 A CN 105287798A CN 201510702945 A CN201510702945 A CN 201510702945A CN 105287798 A CN105287798 A CN 105287798A
- Authority
- CN
- China
- Prior art keywords
- parts
- poria
- polyporus
- chinese medicine
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940023488 Pill Drugs 0.000 title abstract description 30
- 239000006187 pill Substances 0.000 title abstract description 30
- 238000011084 recovery Methods 0.000 title abstract description 6
- 239000003814 drug Substances 0.000 claims abstract description 81
- 241000218176 Corydalis Species 0.000 claims abstract description 40
- 208000004930 Fatty Liver Diseases 0.000 claims abstract description 38
- 206010019708 Hepatic steatosis Diseases 0.000 claims abstract description 38
- 231100000240 steatosis hepatitis Toxicity 0.000 claims abstract description 38
- 229940079593 drugs Drugs 0.000 claims abstract description 35
- 238000002360 preparation method Methods 0.000 claims abstract description 21
- 210000000582 Semen Anatomy 0.000 claims description 48
- 239000000203 mixture Substances 0.000 claims description 41
- 241000222640 Polyporus Species 0.000 claims description 39
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances data:image/svg+xml;base64,PD94bWwgdmVyc2lvbj0nMS4wJyBlbmNvZGluZz0naXNvLTg4NTktMSc/Pgo8c3ZnIHZlcnNpb249JzEuMScgYmFzZVByb2ZpbGU9J2Z1bGwnCiAgICAgICAgICAgICAgeG1sbnM9J2h0dHA6Ly93d3cudzMub3JnLzIwMDAvc3ZnJwogICAgICAgICAgICAgICAgICAgICAgeG1sbnM6cmRraXQ9J2h0dHA6Ly93d3cucmRraXQub3JnL3htbCcKICAgICAgICAgICAgICAgICAgICAgIHhtbG5zOnhsaW5rPSdodHRwOi8vd3d3LnczLm9yZy8xOTk5L3hsaW5rJwogICAgICAgICAgICAgICAgICB4bWw6c3BhY2U9J3ByZXNlcnZlJwp3aWR0aD0nMzAwcHgnIGhlaWdodD0nMzAwcHgnIHZpZXdCb3g9JzAgMCAzMDAgMzAwJz4KPCEtLSBFTkQgT0YgSEVBREVSIC0tPgo8cmVjdCBzdHlsZT0nb3BhY2l0eToxLjA7ZmlsbDojRkZGRkZGO3N0cm9rZTpub25lJyB3aWR0aD0nMzAwLjAnIGhlaWdodD0nMzAwLjAnIHg9JzAuMCcgeT0nMC4wJz4gPC9yZWN0Pgo8dGV4dCB4PScxMDAuNScgeT0nMTcwLjAnIGNsYXNzPSdhdG9tLTAnIHN0eWxlPSdmb250LXNpemU6NDBweDtmb250LXN0eWxlOm5vcm1hbDtmb250LXdlaWdodDpub3JtYWw7ZmlsbC1vcGFjaXR5OjE7c3Ryb2tlOm5vbmU7Zm9udC1mYW1pbHk6c2Fucy1zZXJpZjt0ZXh0LWFuY2hvcjpzdGFydDtmaWxsOiNFODQyMzUnID5IPC90ZXh0Pgo8dGV4dCB4PScxMjYuMScgeT0nMTg2LjAnIGNsYXNzPSdhdG9tLTAnIHN0eWxlPSdmb250LXNpemU6MjZweDtmb250LXN0eWxlOm5vcm1hbDtmb250LXdlaWdodDpub3JtYWw7ZmlsbC1vcGFjaXR5OjE7c3Ryb2tlOm5vbmU7Zm9udC1mYW1pbHk6c2Fucy1zZXJpZjt0ZXh0LWFuY2hvcjpzdGFydDtmaWxsOiNFODQyMzUnID4yPC90ZXh0Pgo8dGV4dCB4PScxMzguMCcgeT0nMTcwLjAnIGNsYXNzPSdhdG9tLTAnIHN0eWxlPSdmb250LXNpemU6NDBweDtmb250LXN0eWxlOm5vcm1hbDtmb250LXdlaWdodDpub3JtYWw7ZmlsbC1vcGFjaXR5OjE7c3Ryb2tlOm5vbmU7Zm9udC1mYW1pbHk6c2Fucy1zZXJpZjt0ZXh0LWFuY2hvcjpzdGFydDtmaWxsOiNFODQyMzUnID5PPC90ZXh0Pgo8L3N2Zz4K data:image/svg+xml;base64,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 O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 30
- 241001057584 Myrrha Species 0.000 claims description 25
- 239000000706 filtrate Substances 0.000 claims description 11
- 238000007493 shaping process Methods 0.000 claims description 5
- 239000002671 adjuvant Substances 0.000 claims description 4
- 230000000240 adjuvant Effects 0.000 claims description 4
- 239000012467 final product Substances 0.000 claims description 3
- 210000004185 Liver Anatomy 0.000 abstract description 14
- 230000000694 effects Effects 0.000 abstract description 13
- 201000010099 disease Diseases 0.000 abstract description 6
- 231100000957 no side effect Toxicity 0.000 abstract description 3
- 230000008929 regeneration Effects 0.000 abstract description 3
- 238000011069 regeneration method Methods 0.000 abstract description 3
- 240000003301 Agrimonia eupatoria Species 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 241000222684 Grifola Species 0.000 abstract 1
- 240000006984 Myristica fragrans Species 0.000 abstract 1
- 235000009421 Myristica fragrans Nutrition 0.000 abstract 1
- 240000001659 Oldenlandia diffusa Species 0.000 abstract 1
- 244000197580 Poria cocos Species 0.000 abstract 1
- 235000008599 Poria cocos Nutrition 0.000 abstract 1
- 235000000125 common agrimony Nutrition 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- 230000002588 toxic Effects 0.000 abstract 1
- 239000000796 flavoring agent Substances 0.000 description 13
- 235000019634 flavors Nutrition 0.000 description 13
- 210000004369 Blood Anatomy 0.000 description 12
- 239000008280 blood Substances 0.000 description 11
- 235000012907 honey Nutrition 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- 210000004072 Lung Anatomy 0.000 description 8
- 230000001225 therapeutic Effects 0.000 description 8
- 208000002193 Pain Diseases 0.000 description 7
- 210000000952 Spleen Anatomy 0.000 description 7
- 230000036407 pain Effects 0.000 description 7
- 241000196324 Embryophyta Species 0.000 description 5
- 210000002784 Stomach Anatomy 0.000 description 5
- 235000009508 confectionery Nutrition 0.000 description 5
- 230000023597 hemostasis Effects 0.000 description 4
- 206010001928 Amenorrhoea Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 208000001848 Dysentery Diseases 0.000 description 3
- 208000001780 Epistaxis Diseases 0.000 description 3
- 206010018987 Haemorrhage Diseases 0.000 description 3
- 210000002216 Heart Anatomy 0.000 description 3
- 208000006454 Hepatitis Diseases 0.000 description 3
- 206010022114 Injury Diseases 0.000 description 3
- 206010025482 Malaise Diseases 0.000 description 3
- 206010030113 Oedema Diseases 0.000 description 3
- 208000004880 Polyuria Diseases 0.000 description 3
- 206010047700 Vomiting Diseases 0.000 description 3
- 201000000736 amenorrhea Diseases 0.000 description 3
- 231100000540 amenorrhea Toxicity 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 230000035619 diuresis Effects 0.000 description 3
- 231100000283 hepatitis Toxicity 0.000 description 3
- 201000009673 liver disease Diseases 0.000 description 3
- 230000025627 positive regulation of urine volume Effects 0.000 description 3
- 230000001737 promoting Effects 0.000 description 3
- 230000001105 regulatory Effects 0.000 description 3
- 210000001015 Abdomen Anatomy 0.000 description 2
- 206010000087 Abdominal pain upper Diseases 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 241000207199 Citrus Species 0.000 description 2
- 240000007311 Commiphora myrrha Species 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 208000000059 Dyspnea Diseases 0.000 description 2
- 206010013975 Dyspnoeas Diseases 0.000 description 2
- 206010013990 Dysuria Diseases 0.000 description 2
- 241000628997 Flos Species 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010019641 Hepatic cirrhosis Diseases 0.000 description 2
- 206010062717 Increased upper airway secretion Diseases 0.000 description 2
- 210000003734 Kidney Anatomy 0.000 description 2
- 235000019687 Lamb Nutrition 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Chemical compound data:image/svg+xml;base64,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 data:image/svg+xml;base64,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 CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- 241000218641 Pinaceae Species 0.000 description 2
- 235000011609 Pinus massoniana Nutrition 0.000 description 2
- 241000018650 Pinus massoniana Species 0.000 description 2
- 241000576755 Sclerotia Species 0.000 description 2
- 206010068760 Ulcers Diseases 0.000 description 2
- 206010051373 Wound haemorrhage Diseases 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 230000001684 chronic Effects 0.000 description 2
- 235000020971 citrus fruits Nutrition 0.000 description 2
- 239000000039 congener Substances 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000002443 hepatoprotective Effects 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 201000004044 liver cirrhosis Diseases 0.000 description 2
- 239000002420 orchard Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- 230000002522 swelling Effects 0.000 description 2
- 230000002195 synergetic Effects 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 241000199899 Alariaceae Species 0.000 description 1
- 206010002156 Anal fistula Diseases 0.000 description 1
- 208000002399 Aphthous Stomatitis Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 208000006820 Arthralgia Diseases 0.000 description 1
- 206010003445 Ascites Diseases 0.000 description 1
- 208000002894 Beriberi Diseases 0.000 description 1
- 210000000988 Bone and Bones Anatomy 0.000 description 1
- 241000905957 Channa melasoma Species 0.000 description 1
- 235000006965 Commiphora myrrha Nutrition 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 208000002173 Dizziness Diseases 0.000 description 1
- 206010058108 Dyslipidaemia Diseases 0.000 description 1
- 210000002683 Foot Anatomy 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010018498 Goitre Diseases 0.000 description 1
- 206010018830 Haematemesis Diseases 0.000 description 1
- 206010018836 Haematochezia Diseases 0.000 description 1
- 208000006750 Hematuria Diseases 0.000 description 1
- 206010019668 Hepatic fibrosis Diseases 0.000 description 1
- 206010019799 Hepatitis viral Diseases 0.000 description 1
- 210000001624 Hip Anatomy 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 241001466452 Laminariaceae Species 0.000 description 1
- 206010061227 Lipid metabolism disease Diseases 0.000 description 1
- 241000607292 Maguireothamnus speciosus Species 0.000 description 1
- 206010027327 Menstrual disease Diseases 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 210000003205 Muscles Anatomy 0.000 description 1
- 241001081833 Myristicaceae Species 0.000 description 1
- 235000007265 Myrrhis odorata Nutrition 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000001140 Night Blindness Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 241000233855 Orchidaceae Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000218180 Papaveraceae Species 0.000 description 1
- 231100000614 Poison Toxicity 0.000 description 1
- 206010049677 Salpingo-oophoritis Diseases 0.000 description 1
- 206010040943 Skin ulcer Diseases 0.000 description 1
- 206010042772 Syncope Diseases 0.000 description 1
- 210000001550 Testis Anatomy 0.000 description 1
- 206010044008 Tonsillitis Diseases 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 210000003932 Urinary Bladder Anatomy 0.000 description 1
- 206010046577 Urinary tract infection Diseases 0.000 description 1
- 231100000611 Venom Toxicity 0.000 description 1
- 210000001048 Venoms Anatomy 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 230000003187 abdominal Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 201000005661 acute cystitis Diseases 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive Effects 0.000 description 1
- 230000001396 anti-anti-diuretic Effects 0.000 description 1
- 231100000319 bleeding Toxicity 0.000 description 1
- 230000000740 bleeding Effects 0.000 description 1
- 201000004569 blindness Diseases 0.000 description 1
- 230000000903 blocking Effects 0.000 description 1
- 230000001914 calming Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 201000008286 diarrhea Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 230000001882 diuretic Effects 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 201000009846 fatty liver disease Diseases 0.000 description 1
- 230000002496 gastric Effects 0.000 description 1
- 201000003872 goiter Diseases 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 230000002650 habitual Effects 0.000 description 1
- 230000003862 health status Effects 0.000 description 1
- 230000002440 hepatic Effects 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000000968 intestinal Effects 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 230000002045 lasting Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 210000004914 menses Anatomy 0.000 description 1
- 230000002175 menstrual Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000003000 nontoxic Effects 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000001717 pathogenic Effects 0.000 description 1
- 230000001575 pathological Effects 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 201000006518 pelvic inflammatory disease Diseases 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 231100000486 side effect Toxicity 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 235000014347 soups Nutrition 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 201000010874 syndrome Diseases 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000002936 tranquilizing Effects 0.000 description 1
- 239000002435 venom Substances 0.000 description 1
- 201000001862 viral hepatitis Diseases 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
- 238000003466 welding Methods 0.000 description 1
Abstract
本发明公开了降脂瘦身复原丸。所述降脂瘦身复原丸包括:昆布40-50份、猪苓40-50份、仙鹤草30-40份、白花蛇舌草30-40份、茯苓25-35份、茜草20-30份、延胡索20-30份、肉豆蔻9-15份。本发明降脂瘦身复原丸按照中药常规制剂方法可制备成任何一种临床上可接受的口服药物制剂。本发明降脂瘦身复原丸具有保肝护肝、降脂祛脂、减肥以抑制脂肪再生之功效,临床疗效表明本发明降脂瘦身复原丸对于脂肪肝疗效确切可靠,标本兼治,临床应用安全,无任何毒副作用。
Description
技术领域
[0001] 本发明涉及一种中药组合物,尤其涉及一种治疗脂肪肝的中药组合物及其制备方 法和用途,属于脂肪肝的中药治疗领域。
背景技术
[0002] 脂肪肝是由多种疾病和原因引起的肝脏脂肪性变,肝内脂肪含量超过肝脏重量的 5%,即称脂肪肝。脂肪性肝病正严重威胁人们的健康,成为仅次于病毒性肝炎的第二大肝 病,已被公认为隐蔽性肝硬化的常见原因。随着我国人民物质生活的不断改善,中国脂肪肝 的发病率逐年升高,由于部分脂肪肝病人可发展为脂肪肝性肝炎和肝纤维化,甚至导致肝 硬化及其各种并发症,所以脂肪肝的防治对阻止慢性肝病进展和改善预后具有重要意义。
[0003] 虽然现有的治疗脂肪肝的可供选择使用的药物较多,但效果不甚理想,西药以化 学方法制作,工艺较复杂、价格高,且经常服用会对胃有刺激。因此,研制一种治疗脂肪肝的 安全、有效的中药新产品具有重大意义。
发明内容
[0004] 本发明所要解决的技术问题是克服现有的治疗脂肪肝存在的见效慢、疗效不持 久、毒副作用大、容易复发等缺陷,提供一种见效快、疗效确切、无毒副作用的治疗脂肪肝的 中药组合物;
[0005] 本发明所要解决的另一个技术问题是提供一种制备上述中药组合物的方法。
[0006] 为解决上述技术问题,本发明所采取的技术方案是:
[0007] 本发明首先公开了一种治疗脂肪肝的中药组合物,包括以下各组分:昆布、猪苓、 仙鹤草、白花蛇舌草、茯苓、茜草、延胡索、肉豆蔻。
[0008] 优选的,各组分的重量份是:昆布40-50份、猪苓40-50份、仙鹤草30-40份、白花 蛇舌草30-40份、茯苓25-35份、茜草20-30份、延胡索20-30份、肉豆蔻9-15份。
[0009] 最优选的,各组分的重量份是:昆布45份、猪苳45份、仙鹤草35份、白花蛇舌草35 份、茯苓30份、茜草25份、延胡索25份、肉豆蔻12份。
[0010] 昆布:为海带科植物海带、或翅藻科植物昆布、裙带菜的叶状体。性味咸,寒。入 胃、脾经。功能主治:软坚,行水。治瘰疬,癭瘤,噎膈,水肿,睾丸肿痛,带下。
[0011] 猪苓:为多孔菌科植物猪苓的干燥菌核。性味甘淡,平。入脾、肾、膀胱经。功能主 治:利尿渗湿。治小便不利,水肿胀满,脚气,泄泻,淋、浊,带下。
[0012] 仙鹤草:为蔷薇科植物龙芽草的全草。性味苦辛,平。入肺、肝、脾经。功能主治: 止血,健胃。治咯血,吐血,尿血,便血,赤白痢疾,崩漏带下,劳伤脱力,痈肿,跌打、创伤出 血。
[0013] 白花蛇舌草:为茜草种植物白花蛇舌草的带根全草。性味苦甘,寒。入心、肝、脾三 经。功能主治:清热,利湿,解毒。治肺热喘咳,扁桃体炎。咽喉炎,阑尾炎,痢疾,尿路感染, 黄疸,肝炎,盆腔炎,附件炎,痈肿疔疮,毒蛇咬伤,肿瘤。亦可用于消化道癌症。
[0014] 茯苓:为多孔菌科植物茯苓的干燥菌核。性味甘淡,平。入心、脾、肺经。功能主 治:渗湿利水,益脾和胃,宁心安神。治小便不利,水肿胀满,痰饮咳逆,呕哕,泄泻,遗精,淋 浊,惊悸,健忘。
[0015] 茜草:为茜草科植物茜草Rubia cordifolia L.的根和根茎。性味苦,寒。入肝 经。功能主治:凉血活血,祛瘀,通经。用于吐血、衄血、崩漏下血、外伤出血、经闭瘀阻、关节 痹痛、跌扑肿痛。凉血止血,活血祛瘀:本品止血而不留瘀,用于热证出血、经闭腹痛、跌打损 伤。
[0016] 延胡索:为罂粟科植物延胡索的块茎。性味辛苦,温。入肝、胃经。功能主治:活 血,散瘀,理气,止痛。治心腹腰膝诸痛,月经不调,症瘕,崩中,产后血晕,恶露不尽,跌打损 伤。
[0017] 肉豆蔻:为肉豆蔻科植物肉豆蔻的种子。性味辛,温。入肺、大肠经。功能主治:温 中,下气,消食,固肠。治心腹胀痛,虚泻冷痢,呕吐,宿食不消。
[0018] 本发明中药组合物是基于发明人对脂肪肝的深层发病机理的研究及其治疗原则, 同时依据发明人多年临床经验和药理学研究成果,筛选出保肝护肝、降脂祛脂、减肥以抑制 脂肪再生的的原料药,按照一定的重量配比组方而成。
[0019] 本发明进一步公开了一种治疗脂肪肝的中药组合物,包括以下各组分:昆布、猪 苓、仙鹤草、白花蛇舌草、茯苓、茜草、延胡索、肉豆蔻、没药、白及、枇杷叶。
[0020] 优选的,各组分的重量份是:昆布40-50份、猪苓40-50份、仙鹤草30-40份、白花 蛇舌草30-40份、茯苓25-35份、茜草20-30份、延胡索20-30份、肉豆蔻9-15份、没药25-35 份、白及9-15份、枇杷叶3-9份。
[0021] 最优选的,各组分的重量份是:昆布45份、猪苳45份、仙鹤草35份、白花蛇舌草35 份、茯苓30份、茜草25份、延胡索25份、肉豆蔻12份、没药30份、白及12份、枇杷叶7份。
[0022] 没药:为橄榄科植物没药树或爱伦堡没药树的胶树脂。性味:苦,平。入肝经。功 能主治:散血去瘀,消肿定痛。治跌损,金疮,筋骨,心腹诸痛,症瘕,经闭,痈疽肿痛,痔漏,目 障。
[0023] 白及:为兰科植物白及的块茎。性味苦甘,凉。入肺经。功能主治:补肺,止血,消 月中,生肌,敛疮。治肺伤咳血,衄血,金疮出血,痈疽肿毒,溃疡疼痛,汤火灼伤,手足皲裂。
[0024] 枇杷叶:为蔷薇科植物枇杷的叶片。性味苦,凉。入肺、胃经。功能主治:清肺和 胃,降气化痰。治肺热痰嗽,咳血,衄血,胃热呕哕。
[0025] 本发明由昆布、猪苓、仙鹤草、白花蛇舌草、茯苓、茜草、延胡索、肉豆蔻制备的中药 组合物对脂肪肝具有一定的治疗效果,有效率达76. 3%。在昆布、猪苓、仙鹤草、白花蛇舌 草、茯苓、茜草、延胡索、肉豆蔻的基础上分别添加了以下四组药物:(1)徐长卿、葛根、绞股 蓝;(2)川楝子、虎杖、陈皮;(3)金银花、白芍、姜黄;(4)没药、白及、枇杷叶;将上述4组药 物组合物分别制备中药组合物,考察其对脂肪肝的治疗效果。实验结果表明,在昆布、猪苓、 仙鹤草、白花蛇舌草、茯苓、茜草、延胡索、肉豆蔻基础上添加没药、白及、枇杷叶对病人的有 效率高达95. 0%,显著高于其它组合。说明昆布、猪苓、仙鹤草、白花蛇舌草、茯苓、茜草、延 胡索、肉豆蔻与没药、白及、枇杷叶配伍在一起具有确切的协同增效功效,有效提高了治疗 脂肪肝的有效率。相比之下,将昆布、猪苓、仙鹤草、白花蛇舌草、茯苓、茜草、延胡索、肉豆蔻 与其它几种药物配伍在一起后,对于提高脂肪肝治疗效果的作用不明显。
[0026] 本发明还公开了一种治疗脂肪肝的中药组合物,包括以下各组分:昆布、猪苓、仙 鹤草、白花蛇舌草、茯苓、茜草、延胡索、肉豆蔻、没药、白及、枇杷叶、决明子、松花粉。
[0027] 优选的,各组分的用量份为:昆布40-50份、猪苓40-50份、仙鹤草30-40份、白花 蛇舌草30-40份、茯苓25-35份、茜草20-30份、延胡索20-30份、肉豆蔻9-15份、没药25-35 份、白及9-15份、枇杷叶3-9份、决明子20-30份、松花粉3-9份。
[0028] 最优选的,各组分的重量份是:昆布45份、猪苳45份、仙鹤草35份、白花蛇舌草35 份、茯苓30份、茜草25份、延胡索25份、肉豆蔻12份、没药30份、白及12份、枇杷叶7份、 决明子25份、松花粉7份。
[0029] 决明子:为豆科植物决明的成熟种子。性味苦甘,凉。入肝、肾经。功能主治:清 肝,明目,利水,通便。治风热赤眼,青盲,雀目,高血压,肝炎,肝硬化腹水,习惯性便秘。 [0030] 松花粉:为松科植物马尾松或其同属植物的花粉。性味为松科植物马尾松或其同 属植物的花粉。入肝、脾经。功能主治:祛风益气,收湿,止血。治头旋眩晕,中虚胃疼,久 痢,诸疮湿烂,创伤出血。
[0031] 本发明方中各药配伍在一起起到保肝护肝、降脂祛脂、减肥以抑制脂肪再生之功 效。本发明中药组合物对于脂肪肝标本兼治,临床疗效观察证实,本发明中药组合物对于脂 肪肝疗效确切可靠、真实。本发明中药组合物无毒无害,安全可靠,服用后无不良反应,临床 使用安全。
[0032] 本发明所用的各味原料药都可以在医药商店购买得到。
[0033] 本发明药物活性组分可以加入制备不同剂型时所需的各种辅料,例如崩解剂、润 滑剂、黏合剂等,以常规的中药制剂方法制备成任何一种适宜的临床口服制剂,所述的口服 制剂可以是丸剂、散剂、颗粒剂、胶囊剂、片剂、口服液、滴丸剂等。
[0034] 本发明中药组合物的一种制备方法:将本发明的各原料药按所述重量份配比称取 后,粉碎,过筛(例如可以是80-300目筛),即得。当然,也可以将各原料药粉碎后,加入制 剂成型所需的辅料或赋型剂,按照常规方法制备成胶囊剂、片剂或丸剂。
[0035] 本发明中药组合物的另一种制备方法:按所述重量份称取各原料药;将各原料药 用水煎煮,合并煎煮液,过滤,滤液浓缩成清膏,加入制剂成型的辅料或赋型剂,制剂成型, 即得。
[0036] 本发明中药组合物的用法与用量:本发明的用药量取决于具体剂型、病人的年龄、 健康状况等因素。作为指导:用法用量:丸剂,每丸丸剂含〇. 6克生药,每次口服2至3丸, 一日3次。
具体实施方式
[0037] 下面结合具体实施例来进一步描述本发明,这些实施例仅是范例性的,本领域技 术人员应该理解的是,在不偏离本发明的精神和范围下可以对本发明技术方案的细节和形 式进行修改或替换,但这些修改和替换均落入本发明的保护范围内。
[0038] 实施例1丸剂的制备
[0039] 按以下重量称取各原料药:昆布40g、猪苓40g、仙鹤草30g、白花蛇舌草30g、茯苓 25g、茜草20g、延胡索20g、肉豆蔻9g ;将上述各原料药加水煎煮二次,第一次加4倍重量的 水,煎煮2小时,第二次加5倍重量的水,煎煮1. 5小时;将煎煮液合并,滤过,滤液浓缩至相 对密度为1. 17-1. 19 (60°C )的清膏;加适量炼蜜,混匀,制备成每粒6g的药丸。
[0040] 实施例2丸剂的制备
[0041] 按以下重量称取各原料药:昆布50g、猪苓50g、仙鹤草40g、白花蛇舌草40g、茯苓 35g、茜草30g、延胡索30g、肉豆蔻15g ;将上述各原料药加水煎煮二次,第一次加4倍重量 的水,煎煮2小时,第二次加5倍重量的水,煎煮1. 5小时;将煎煮液合并,滤过,滤液浓缩至 相对密度为1. 17-1. 19 (60°C )的清膏;加适量炼蜜,混匀,制备成每粒6g的药丸。
[0042] 实施例3丸剂的制备
[0043] 按以下重量称取各原料药:昆布45g、猪苓45g、仙鹤草35g、白花蛇舌草35g、茯苓 30g、茜草25g、延胡索25g、肉豆蔻12g ;将上述各原料药加水煎煮二次,第一次加4倍重量 的水,煎煮2小时,第二次加5倍重量的水,煎煮1. 5小时;将煎煮液合并,滤过,滤液浓缩至 相对密度为1. 17-1. 19 (60°C )的清膏;加适量炼蜜,混匀,制备成每粒6g的药丸。
[0044] 实施例4丸剂的制备
[0045] 按以下重量称取各原料药:昆布40g、猪苓40g、仙鹤草30g、白花蛇舌草30g、茯苓 25g、茜草20g、延胡索20g、肉豆蔻9g、没药25g、白及9g、枇杷叶3g ;将上述各原料药加水煎 煮二次,第一次加4倍重量的水,煎煮2小时,第二次加5倍重量的水,煎煮1. 5小时;将煎 煮液合并,滤过,滤液浓缩至相对密度为1. 17-1. 19(60°C )的清膏;加适量炼蜜,混匀,制备 成每粒6g的药丸。
[0046] 实施例5丸剂的制备
[0047] 按以下重量称取各原料药:昆布50g、猪苓50g、仙鹤草40g、白花蛇舌草40g、茯苓 35g、茜草30g、延胡索30g、肉豆蔻15g、没药35g、白及15g、枇杷叶9g ;将上述各原料药加水 煎煮二次,第一次加4倍重量的水,煎煮2小时,第二次加5倍重量的水,煎煮1. 5小时;将 煎煮液合并,滤过,滤液浓缩至相对密度为1. 17-1. 19 (60°C )的清膏;加适量炼蜜,混匀,制 备成每粒6g的药丸。
[0048] 实施例6丸剂的制备
[0049] 按以下重量称取各原料药;昆布45g、猪苓45g、仙鹤草35g、白花蛇舌草35g、茯苓 30g、茜草25g、延胡索25g、肉豆蔻12g、没药30g、白及12g、枇杷叶7g ;将上述各原料药加水 煎煮二次,第一次加4倍重量的水,煎煮2小时,第二次加5倍重量的水,煎煮1. 5小时;将 煎煮液合并,滤过,滤液浓缩至相对密度为1. 17-1. 19 (60°C )的清膏;加适量炼蜜,混匀,制 备成每粒6g的药丸。
[0050] 实施例7丸剂的制备
[0051] 按以下重量称取各原料药:昆布40g、猪苓40g、仙鹤草30g、白花蛇舌草30g、茯苓 25g、茜草20g、延胡索20g、肉豆蔻9g、没药25g、白及9g、枇杷叶3g、决明子20g、松花粉3g ; 将上述各原料药加水煎煮二次,第一次加4倍重量的水,煎煮2小时,第二次加5倍重量的 水,煎煮1. 5小时;将煎煮液合并,滤过,滤液浓缩至相对密度为1. 17-1. 19 (60°C )的清膏; 加适量炼蜜,混匀,制备成每粒6g的药丸。
[0052] 实施例8丸剂的制备
[0053] 按以下重量称取各原料药:昆布50g、猪苓50g、仙鹤草40g、白花蛇舌草40g、茯苓 35g、茜草30g、延胡索30g、肉豆蔻15g、没药35g、白及15g、枇杷叶9g、决明子30g、松花粉 9g ;将上述各原料药加水煎煮二次,第一次加4倍重量的水,煎煮2小时,第二次加5倍重量 的水,煎煮1. 5小时;将煎煮液合并,滤过,滤液浓缩至相对密度为1. 17-1. 19 (60°C )的清 膏;加适量炼蜜,混匀,制备成每粒6g的药丸。
[0054] 实施例9丸剂的制备
[0055] 按以下重量称取各原料药:昆布45g、猪苓45g、仙鹤草35g、白花蛇舌草35g、茯苓 30g、茜草25g、延胡索25g、肉豆蔻12g、没药30g、白及12g、枇杷叶7g、决明子25g、松花粉 7g ;将上述各原料药加水煎煮二次,第一次加4倍重量的水,煎煮2小时,第二次加5倍重量 的水,煎煮1. 5小时;将煎煮液合并,滤过,滤液浓缩至相对密度为1. 17-1. 19 (60°C )的清 膏;加适量炼蜜,混匀,制备成每粒6g的药丸。
[0056] 实验例1应用本发明中药组合物治疗脂肪肝的临床疗效观察试验
[0057] -、一般资料:
[0058] 400例患者均符合脂肪肝的诊断标准,将患者随机分成5组,每组80例;5组在性 另IJ、年龄、病程及病情严重程度上差异无显著性。诊断标准:1、症状:肥胖、腹胀、乏力、肝区 痛等;2、血脂异常;3、B超或CT检查肝脏可见脂肪肝的特征性病变;4、肝穿刺,病理检查诊 断为脂肪肝。
[0059] 二、药物制备
[0060] 中药组合物1,按照以下重量称取各组分:昆布45g、猪苓45g、仙鹤草35g、白花蛇 舌草35g、茯苳30g、茜草25g、延胡索25g、肉豆蔻12g ;
[0061] 中药组合物2 :在中药组合物1基础上添加徐长卿30g、葛根12g、绞股蓝7g ;
[0062] 中药组合物3 :在中药组合物1基础上添加川楝子30g、虎杖12g、陈皮7g ;
[0063] 中药组合物4 :在中药组合物1基础上添加金银花30g、白芍12g、姜黄;
[0064] 中药组合物5 :在中药组合物1基础上添加没药30g、白及12g、枇杷叶7g ;
[0065] 三、治疗方法
[0066] 分别用上述中药组合物1-5的丸剂对上述5组脂肪肝患者进行治疗;口服,一次2 丸(〇. 6g生药/丸),一日3次,早中晚各一次,10天为一疗程,共治疗2-3个疗程;服药期 间停服其它相关药物及其它治疗。
[0067] 四、疗效评定标准
[0068] 痊愈:肝B超检查:脂肪肝消失,肝功能正常,不适症状、体征消失;
[0069] 有效:肝B超检查:脂肪肝出现好转,不适症状、体征消失;
[0070] 无效:脂肪肝症状无好转或逐渐加重。
[0071] 五、临床观察结果
[0072] 临床观察结果见表1。
[0073] 表1不同中药组合物治疗脂肪肝的统计结果
[0076] 结果表明,由昆布、猪苓、仙鹤草、白花蛇舌草、茯苓、茜草、延胡索、肉豆蔻制备的 中药组合物1对脂肪肝具有一定的治疗效果,有效率达76. 3%。在昆布、猪苓、仙鹤草、白花 蛇舌草、茯苓、茜草、延胡索、肉豆蔻基础上,添加没药、白及和枇杷叶,对治疗脂肪肝的有效 率显著提高,达到95. 0%。
[0077] 以上结果说明,昆布、猪苓、仙鹤草、白花蛇舌草、茯苓、茜草、延胡索、肉豆蔻与没 药、白及和枇杷叶之间具有显著的协同增效作用,将其配伍在一起能够显著提高治疗脂肪 肝的有效率。相比之下,将昆布、猪苓、仙鹤草、白花蛇舌草、茯苓、茜草、延胡索、肉豆蔻与其 它几种药物配伍在一起后,对于提高脂肪肝治疗效果的作用不明显。安全性观察发现,没有 观察到任何临床不良反应,表明本发明中药组合物临床应用安全、无毒副作用。
Claims (9)
1. 一种治疗脂肪肝的中药组合物,其特征在于,由以下各组分组成:昆布、猪苓、仙鹤 草、白花蛇舌草、茯苓、茜草、延胡索、肉豆蔻。
2.按照权利要求1所述的中药组合物,其特征在于,各组分的重量份是:昆布40-50 份、猪苓40-50份、仙鹤草30-40份、白花蛇舌草30-40份、茯苓25-35份、茜草20-30份、延 胡索20-30份、肉豆蔻9-15份。
3.按照权利要求2所述的中药组合物,其特征在于,各组分的重量份是:昆布45份、猪 苓45份、仙鹤草35份、白花蛇舌草35份、茯苓30份、茜草25份、延胡索25份、肉豆蔻12 份。
4. 一种治疗脂肪肝的中药组合物,其特征在于,由以下各组分组成:昆布、猪苓、仙鹤 草、白花蛇舌草、茯苓、茜草、延胡索、肉豆蔻、没药、白及、枇杷叶。
5.按照权利要求4所述的中药组合物,其特征在于,各组分的重量份是:昆布40-50 份、猪苓40-50份、仙鹤草30-40份、白花蛇舌草30-40份、茯苓25-35份、茜草20-30份、延 胡索20-30份、肉豆蔻9-15份、没药25-35份、白及9-15份、枇杷叶3-9份。
6. 按照权利要求5所述的中药组合物,其特征在于,各组分的重量份是:昆布45份、猪 苓45份、仙鹤草35份、白花蛇舌草35份、茯苓30份、茜草25份、延胡索25份、肉豆蔻12 份、没药30份、白及12份、枇杷叶7份。
7. -种治疗脂肪肝的中药组合物,其特征在于,由以下各组分组成:昆布、猪苓、仙鹤 草、白花蛇舌草、茯苓、茜草、延胡索、肉豆蔻、没药、白及、枇杷叶、决明子、松花粉;优选的, 各组分的用量份为:昆布40-50份、猪苓40-50份、仙鹤草30-40份、白花蛇舌草30-40份、 茯苓25-35份、茜草20-30份、延胡索20-30份、肉豆蔻9-15份、没药25-35份、白及9-15 份、枇杷叶3-9份、决明子20-30份、松花粉3-9份;最优选的,各组分的重量份是:昆布45 份、猪苓45份、仙鹤草35份、白花蛇舌草35份、茯苓30份、茜草25份、延胡索25份、肉豆 蔻12份、没药30份、白及12份、枇杷叶7份、决明子25份、松花粉7份。
8. -种制备权利要求1-7任何一项所述中药组合物的方法,包括以下步骤: (1) 、按所述重量配比称取各原料药; (2) 、将各原料药用水煎煮,合并煎煮液,过滤,滤液浓缩成清膏,加入制剂成型的辅料 或赋型剂,制剂成型,即得。
9.权利要求1-7任何一项所述中药组合物在制备治疗脂肪肝药物中的用途。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510702945.2A CN105287798A (zh) | 2015-10-24 | 2015-10-24 | 降脂瘦身复原丸 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201510702945.2A CN105287798A (zh) | 2015-10-24 | 2015-10-24 | 降脂瘦身复原丸 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN105287798A true CN105287798A (zh) | 2016-02-03 |
Family
ID=55186085
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201510702945.2A Pending CN105287798A (zh) | 2015-10-24 | 2015-10-24 | 降脂瘦身复原丸 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105287798A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106491749A (zh) * | 2017-01-12 | 2017-03-15 | 青岛大学附属医院 | 用于预防和/或治疗肝纤维化的中药组合物 |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103071108A (zh) * | 2012-12-14 | 2013-05-01 | 葛晓云 | 一种治疗脂肪肝的口服药 |
CN103520657A (zh) * | 2013-10-25 | 2014-01-22 | 山东大学 | 一种治疗肥胖性脂肪肝的中药组合物 |
CN104547774A (zh) * | 2015-01-14 | 2015-04-29 | 孙顺新 | 一种治疗肝病的中药组合物及其制备方法与用途 |
-
2015
- 2015-10-24 CN CN201510702945.2A patent/CN105287798A/zh active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103071108A (zh) * | 2012-12-14 | 2013-05-01 | 葛晓云 | 一种治疗脂肪肝的口服药 |
CN103520657A (zh) * | 2013-10-25 | 2014-01-22 | 山东大学 | 一种治疗肥胖性脂肪肝的中药组合物 |
CN104547774A (zh) * | 2015-01-14 | 2015-04-29 | 孙顺新 | 一种治疗肝病的中药组合物及其制备方法与用途 |
Non-Patent Citations (1)
Title |
---|
吴科研等: "中医药治疗脂肪肝研究进展", 《光明中医》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106491749A (zh) * | 2017-01-12 | 2017-03-15 | 青岛大学附属医院 | 用于预防和/或治疗肝纤维化的中药组合物 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103432559B (zh) | 一种治疗血滞型月经减少及痛经的中药组合物及其制备方法和用途 | |
CN103638502B (zh) | 一种治疗白塞病的药物及其制备方法 | |
CN102106965B (zh) | 一种治疗软组织急性损伤的组合物及其应用 | |
CN105168460A (zh) | 治疗原发性三叉神经痛的制剂 | |
CN103908616B (zh) | 缓解肿瘤病人放疗反应的药剂及制备方法 | |
CN105521332A (zh) | 治疗肛裂的中药组合物及其制备方法和应用 | |
CN105287798A (zh) | 降脂瘦身复原丸 | |
CN104257986A (zh) | 一种治疗肾炎的中药 | |
CN103948899A (zh) | 一种治疗萎缩性胃炎的藏药 | |
CN104338052A (zh) | 治疗脑血栓的中药配方 | |
CN103127398B (zh) | 一种治疗癌症的中药及其制备方法 | |
CN106309561A (zh) | 一种治疗牙痛的药物及其制备方法 | |
CN104771732A (zh) | 一种治疗过敏性哮喘的中药组合物 | |
CN103550351A (zh) | 治疗偏头疼的中药组合物及其制备方法 | |
CN109331164A (zh) | 一种治疗狂犬病的中药组合物,中药提取物及其制备方法和剂型 | |
CN105535760A (zh) | 一种治疗冠心病的中药组合物及其制备方法和用途 | |
CN105560856A (zh) | 治疗周围神经炎的中药组合物及其制备方法和应用 | |
CN105343836A (zh) | 一种治疗慢性胃炎的药物及其制备方法 | |
CN105535769A (zh) | 治疗食管贲门失弛缓症的中药组合物及其制备方法和应用 | |
CN105853900A (zh) | 肝癌患者放疗期间服用的中药制剂及制法 | |
CN105816721A (zh) | 一种戒除毒瘾的中药组合物及其制备方法和用途 | |
CN105326997A (zh) | 一种治疗胃溃疡的中药制剂 | |
CN105902948A (zh) | 一种医治慢性胃溃疡的制剂及制法 | |
CN105497799A (zh) | 一种治疗癫狂症的内服中药丸及其制备方法 | |
CN105560513A (zh) | 治疗面神经麻痹的中药组合物及其制备方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
C06 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
C10 | Entry into substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160203 |
|
RJ01 | Rejection of invention patent application after publication |